• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经验教训:将高清循环肿瘤细胞检测平台转化为商业化临床检测平台进行开发。

Lessons Learned: Transfer of the High-Definition Circulating Tumor Cell Assay Platform to Development as a Commercialized Clinical Assay Platform.

作者信息

Kuhn P, Keating S M, Baxter G T, Thomas K, Kolatkar A, Sigman C C

机构信息

The Scripps Research Institute, La Jolla, California, USA.

CCS Associates, San Jose, California, USA.

出版信息

Clin Pharmacol Ther. 2017 Nov;102(5):777-785. doi: 10.1002/cpt.645. Epub 2017 Mar 22.

DOI:10.1002/cpt.645
PMID:28160285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5653379/
Abstract

Planning and transfer of a new technology platform developed in an academic setting to a start-up company for medical diagnostic product development may appear daunting and costly in terms of complexity, time, and resources. In this review we outline the key steps taken and lessons learned when a technology platform developed in an academic setting was transferred to a start-up company for medical diagnostic product development in the interest of elucidating development toolkits for academic groups and small start-up companies starting on the path to commercialization and regulatory approval.

摘要

将在学术环境中开发的新技术平台转移到一家初创公司用于医疗诊断产品开发,在复杂性、时间和资源方面可能显得艰巨且成本高昂。在本综述中,我们概述了为了阐明面向开始走向商业化和监管批准道路的学术团体和小型初创公司的开发工具包,当一个在学术环境中开发的技术平台被转移到一家初创公司用于医疗诊断产品开发时所采取的关键步骤和吸取的经验教训。

相似文献

1
Lessons Learned: Transfer of the High-Definition Circulating Tumor Cell Assay Platform to Development as a Commercialized Clinical Assay Platform.经验教训:将高清循环肿瘤细胞检测平台转化为商业化临床检测平台进行开发。
Clin Pharmacol Ther. 2017 Nov;102(5):777-785. doi: 10.1002/cpt.645. Epub 2017 Mar 22.
2
Circulating tumor cells: Ready for translation?循环肿瘤细胞:准备好转化了吗?
J Exp Med. 2020 Aug 3;217(8). doi: 10.1084/jem.20200356.
3
Your idea and your university: issues in academic technology transfer.你的创意与大学:学术技术转移中的问题。
J Investig Med. 2011 Jun;59(5):752-7. doi: 10.2310/JIM.0b013e31820d0fdf.
4
Scientific diligence for oncology drugs: a pharmacology, translational medicine and clinical perspective.肿瘤药物的科学严谨性:药理学、转化医学及临床视角
Drug Discov Today. 2020 Oct;25(10):1855-1864. doi: 10.1016/j.drudis.2020.07.014. Epub 2020 Jul 18.
5
Hurdles in tissue engineering/regenerative medicine product commercialization: a pilot survey of governmental funding agencies and the financial industry.组织工程/再生医学产品商业化中的障碍:政府资助机构和金融行业的试点调查。
Tissue Eng Part A. 2012 Nov;18(21-22):2187-94. doi: 10.1089/ten.TEA.2012.0186. Epub 2012 Sep 27.
6
Spatiotemporal molecular medicine: A new era of clinical and translational medicine.时空分子医学:临床与转化医学的新时代。
Clin Transl Med. 2021 Jan;11(1):e294. doi: 10.1002/ctm2.294.
7
Evolution of Translational Bioinformatics: lessons learned from TBC 2016.转化生物信息学的发展:从2016年转化生物信息学大会汲取的经验教训
BMC Med Genomics. 2017 May 24;10(Suppl 1):32. doi: 10.1186/s12920-017-0262-5.
8
Bench to bedside: integrating advances in basic science into daily clinical practice.从实验室到临床:将基础科学进展融入日常临床实践
Hand Clin. 2014 Aug;30(3):305-17, vi. doi: 10.1016/j.hcl.2014.04.004. Epub 2014 Jun 6.
9
The road from discovery to clinical diagnostics: lessons learned from the first FDA-cleared in vitro diagnostic multivariate index assay of proteomic biomarkers.从发现到临床诊断的道路:从首个获得 FDA 批准的基于蛋白质组生物标志物的体外诊断多变量指数分析试剂盒中获得的经验教训。
Cancer Epidemiol Biomarkers Prev. 2010 Dec;19(12):2995-9. doi: 10.1158/1055-9965.EPI-10-0580. Epub 2010 Oct 20.
10
Editorial: Diagnosis and Treatment of Primary Aldosteronism: from Clinical Origin to Translational Research.社论:原发性醛固酮增多症的诊断与治疗:从临床起源到转化研究
Front Endocrinol (Lausanne). 2021 Nov 30;12:781105. doi: 10.3389/fendo.2021.781105. eCollection 2021.

引用本文的文献

1
Characterization of Cellular and Acellular Analytes from Pre-Cystectomy Liquid Biopsies in Patients Newly Diagnosed with Primary Bladder Cancer.新诊断原发性膀胱癌患者膀胱切除术前液体活检中细胞和无细胞分析物的特征分析
Cancers (Basel). 2022 Feb 1;14(3):758. doi: 10.3390/cancers14030758.
2
Applications of liquid biopsy in the Pharmacological Audit Trail for anticancer drug development.液体活检在抗癌药物开发的药理学审核追踪中的应用。
Nat Rev Clin Oncol. 2021 Jul;18(7):454-467. doi: 10.1038/s41571-021-00489-x. Epub 2021 Mar 24.
3
Circulating Tumor Cells and Circulating Tumor DNA Detection in Potentially Resectable Metastatic Colorectal Cancer: A Prospective Ancillary Study to the Unicancer Prodige-14 Trial.

本文引用的文献

1
US FDA and personalized medicine: in vitro diagnostic regulatory perspective.美国食品药品监督管理局与个性化医疗:体外诊断监管视角
Per Med. 2010 Sep;7(5):517-530. doi: 10.2217/pme.10.53.
2
Detection and Characterization of Circulating Tumour Cells from Frozen Peripheral Blood Mononuclear Cells.从冷冻外周血单个核细胞中检测和鉴定循环肿瘤细胞
J Circ Biomark. 2015 May 13;4:4. doi: 10.5772/60745. eCollection 2015 Jan-Dec.
3
Analytical Validation and Capabilities of the Epic CTC Platform: Enrichment-Free Circulating Tumour Cell Detection and Characterization.
在潜在可切除转移性结直肠癌中循环肿瘤细胞和循环肿瘤 DNA 的检测:UNICANCER Prodige-14 试验的一项辅助前瞻性研究。
Cells. 2019 May 28;8(6):516. doi: 10.3390/cells8060516.
4
Biomarkers: What Role Do They Play (If Any) for Diagnosis, Prognosis and Tumor Response Prediction for Hepatocellular Carcinoma?生物标志物:它们在肝细胞癌的诊断、预后和肿瘤反应预测方面(如果有的话)扮演什么角色?
Dig Dis Sci. 2019 Apr;64(4):918-927. doi: 10.1007/s10620-019-05517-6.
Epic循环肿瘤细胞平台的分析验证及能力:无需富集的循环肿瘤细胞检测与表征
J Circ Biomark. 2015 May 5;4:3. doi: 10.5772/60725. eCollection 2015 Jan-Dec.
4
Technology transfer: The leap to industry.技术转让:迈向产业的飞跃。
Nature. 2016 May 5;533(7601):S13-5. doi: 10.1038/533S13a.
5
Challenges in circulating tumor cell detection by the CellSearch system.CellSearch系统在循环肿瘤细胞检测中的挑战。
Mol Oncol. 2016 Mar;10(3):395-407. doi: 10.1016/j.molonc.2015.12.002. Epub 2015 Dec 25.
6
Biotech boot camp.生物技术新兵训练营。
Nature. 2015 Mar 26;519(7544):402-5. doi: 10.1038/519402a.
7
Biology, detection, and clinical implications of circulating tumor cells.循环肿瘤细胞的生物学特性、检测方法及其临床意义
EMBO Mol Med. 2015 Jan;7(1):1-11. doi: 10.15252/emmm.201303698.
8
Rapid phenotypic and genomic change in response to therapeutic pressure in prostate cancer inferred by high content analysis of single circulating tumor cells.通过对单个循环肿瘤细胞的高内涵分析推断,前列腺癌在治疗压力下的快速表型和基因组变化。
PLoS One. 2014 Aug 1;9(8):e101777. doi: 10.1371/journal.pone.0101777. eCollection 2014.
9
Evidence of clinical utility: an unmet need in molecular diagnostics for patients with cancer.临床效用证据:癌症患者分子诊断未满足的需求。
Clin Cancer Res. 2014 Mar 15;20(6):1428-44. doi: 10.1158/1078-0432.CCR-13-2961.
10
Innovation: Bridging the market gap.创新:弥合市场差距。
Nature. 2013 Sep 26;501(7468):483-5. doi: 10.1038/501483a.